Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.
about
Cardiotoxicity in childhood cancer survivors: strategies for prevention and managementMyocardial diseases of animalsThe minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity.21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine.The utility of serum biomarkers to detect myocardial alterations induced by Imatinib in rats.Anthracycline cardiotoxicity: from bench to bedside.Cardiovascular effects in childhood cancer survivors treated with anthracyclines.Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells.Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance.Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Strategies to prevent anthracycline-related congestive heart failure in survivors of childhood cancer.Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity.Cardiovascular disease in survivors of hematopoietic cell transplantation.Nanomedicine as an emerging platform for metastatic lung cancer therapy.Cardiomyopathy in Childhood Cancer Survivors: Lessons from the Past and Challenges for the Future.Using biomarkers to predict and to prevent cardiotoxicity of cancer therapy.Ferric carboxymaltose-mediated attenuation of Doxorubicin-induced cardiotoxicity in an iron deficiency rat model.Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats.A multifaceted evaluation of imatinib-induced cardiotoxicity in the rat.Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat.Cardiac damage in rodents after exposure to bis(2-chloroethoxy)methane.Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice.Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.Mechanisms and biomarkers of cardiovascular injury induced by phosphodiesterase inhibitor III SK&F 95654 in the spontaneously hypertensive rat.Safety Pharmacology Society: 9th Annual Meeting.Anthracycline cardiotoxicity: the importance of horizontally integrating pre-clinical and clinical research.The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.
P2860
Q24628695-1C3C0F3C-DB03-460B-96D5-9900C92C1A9AQ27478460-9B2DEEB8-B27C-44A9-8503-A4BD4F0C5D82Q33427938-A2373FFE-37CD-4003-8F9E-909F9C22DB21Q33900003-0FB94C53-C192-4398-8307-34625A927F5FQ34292469-9E28DDED-C835-4747-9CC1-A6A305DDC816Q34477415-E1FB3197-BC22-483E-A2FD-9A10E9DE1027Q34572109-5F2695A4-D4C1-49B1-865A-BD53B50CF64BQ35078142-1B06CB05-5EE4-4356-B0B8-BD3FDAF443BAQ35189961-ABFD6208-128C-4E22-80D3-411F073484B7Q35604039-ACE23913-AAAD-4538-9B60-137193DCC634Q36184665-279475D3-7624-4BC6-AA64-FF68AA58741AQ36440055-839C73BB-1956-42E9-8DCB-EA7BCCBF424CQ37495209-14CB56D3-0540-43F4-96DE-77064C5FD202Q37624268-79EEBC86-271D-416A-9D53-22939364A4DAQ38463092-206CA60F-A672-4A5B-8055-EA0379A4A0F6Q38753035-BA8266F5-9B84-4011-A5FB-F17FA58842CEQ39018351-F2457D9E-D28B-4207-A671-701F3DF912D1Q39642839-5CF0A83D-75D6-4055-AB95-798A1FBB26CBQ42277607-ECEC41B4-FE2C-4592-87A6-CDB7A9CB6FF5Q42726669-6151741B-FE38-4DD6-BAA9-9CFC99142E65Q44086407-C3E8CA86-528D-4CCE-A3E8-6D637297CE94Q44942444-D9E37A51-6A56-4AC3-8131-380FCC1378C3Q46762955-70A6401D-CA7C-46D6-8F20-974246BE998CQ46797043-97572AC1-8574-4B0A-8D04-009DEE0E03E6Q46990416-952F9817-318B-4CC5-9629-7746BD68098FQ48309631-4336229A-D715-4B07-8A2F-0EFEA27104CEQ49617830-4D0204EB-3F94-4256-8727-AA4BF36ED0DDQ50946920-DB5F679E-13C2-4237-8B8C-05F5E5A34317
P2860
Comparison of the severity of the chronic cardiotoxicity produced by doxorubicin in normotensive and hypertensive rats.
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
1985年论文
@zh
1985年论文
@zh-cn
name
Comparison of the severity of ...... tensive and hypertensive rats.
@en
Comparison of the severity of ...... tensive and hypertensive rats.
@nl
type
label
Comparison of the severity of ...... tensive and hypertensive rats.
@en
Comparison of the severity of ...... tensive and hypertensive rats.
@nl
prefLabel
Comparison of the severity of ...... tensive and hypertensive rats.
@en
Comparison of the severity of ...... tensive and hypertensive rats.
@nl
P2093
P1476
Comparison of the severity of ...... tensive and hypertensive rats.
@en
P2093
P304
P356
10.1016/0041-008X(85)90284-4
P577
1985-04-01T00:00:00Z